BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
4.060
+0.030 (0.74%)
At close: Apr 28, 2026, 4:00 PM EDT
3.990
-0.070 (-1.72%)
After-hours: Apr 28, 2026, 5:56 PM EDT
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $29.18 million as of April 28, 2026. Its market cap has increased by 95.81% in one year.
Market Cap
29.18M
Enterprise Value
-1.31M
1-Year Change
95.81%
Ranking
Category
Stock Price
$4.06
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has increased from $26.00M to $29.18M, an increase of 12.21%. That is a compound annual growth rate of 2.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 29.20M | 117.91% |
| Dec 31, 2025 | 13.40M | -46.40% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tvardi Therapeutics | 29.08M |
| Lisata Therapeutics | 28.90M |
| Kyntra Bio | 28.89M |
| Apollomics | 28.52M |
| Polyrizon | 27.74M |
| Lantern Pharma | 27.57M |
| Longeveron | 27.52M |
| NanoViricides | 27.21M |